"I'm not going to change until the science changes, and the science does not look like it's changing. It's getting stronger and stronger every day. What we recommend is that mothers, pregnant mothers, talk to their physicians. The mothers of small kids talk to their physicians, and we've advised the physicians to reduce the thresholds and to reduce the amount of Tylenol that they give to children as much as possible, and only use it when it's absolutely critical."
"MAHA is critical. America will have to get fit in order to right-side the healthcare system, and MAHA has the answers. It has obesity management through diet and exercise and sleep and dealing with issues related to that. And I want to say it as clear as I can: Obesity is not an absence of GLP-1 drugs. We're all clear on that. But as Secretary Kennedy said, it is an arrow in our quiver that we must use and should use."
Controversial claims assert Tylenol use during pregnancy and early childhood poses risks and will not change absent new science. Recommendations urge pregnant mothers and parents of small children to consult physicians. Physicians are advised to lower dosing thresholds and limit Tylenol use in children to critical situations only. A health initiative called MAHA emphasizes obesity management through diet, exercise, sleep, and related behavioral measures. GLP-1 weight-loss drugs are presented as an additional tool, not a replacement for lifestyle changes, with a call to reduce the cost of those medicines to improve access.
Read at www.mediaite.com
Unable to calculate read time
Collection
[
|
...
]